insights into the management of mds/mpn overlap syndromes & advice for clinicians
Published 1 month ago • 84 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
1:12
insights into the optimal management of cll: the importance of patient characteristics
-
2:33
insights into the results and implications of the commands & imerge studies in lr-mds
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:07
challenges associated with the management of extramedullary myeloma & ongoing research
-
4:25
the challenges with accurately diagnosing and risk-stratifying patients with mds
-
1:18
the importance risk stratification to enable risk-adapted therapy in mds & cmml
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
5:22
magrolimab azacitidine in mds and aml
-
4:39
imetelstat shows promise in advanced myelofibrosis
-
13:39
key highlights in mds: treating lower-risk & higher-risk disease, trial updates, and more
-
2:45
an insight into clinical risk factors for progression in mpns
-
3:21
an insight into the standard of care in hr-mds and future outlooks
-
2:43
novel therapies in the future of mds treatment
-
1:14
modern prognostication in mpns: improving risk stratification & treatment approaches
-
1:23
insights into the management and treatment of accelerated/blast-phase mpns
-
3:19
key clinical trials in mds taking place in the us
-
3:37
progress in the categorization and treatment of lr-mds
-
4:48
an insight into the management of cytopenias in mf
-
2:04
state-of-the-art treatment for hr-mds
-
1:22
key advances in mds management
-
2:06
outcomes & promising treatment options following hma failure in patients with hr-mds